-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Total costs of sales and operating expenses for the period.
-
Summary
-
Acer Therapeutics Inc. quarterly Costs and Expenses history and growth rate from Q3 2022 to Q3 2023.
- Acer Therapeutics Inc. Costs and Expenses for the quarter ending September 30, 2023 was $13.2M, a 153% increase year-over-year.
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)